These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30479275)

  • 1. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
    Manthei KA; Yang SM; Baljinnyam B; Chang L; Glukhova A; Yuan W; Freeman LA; Maloney DJ; Schwendeman A; Remaley AT; Jadhav A; Tesmer JJ
    Elife; 2018 Nov; 7():. PubMed ID: 30479275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.
    Freeman LA; Demosky SJ; Konaklieva M; Kuskovsky R; Aponte A; Ossoli AF; Gordon SM; Koby RF; Manthei KA; Shen M; Vaisman BL; Shamburek RD; Jadhav A; Calabresi L; Gucek M; Tesmer JJG; Levine RL; Remaley AT
    J Pharmacol Exp Ther; 2017 Aug; 362(2):306-318. PubMed ID: 28576974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel LCAT (Lecithin:Cholesterol Acyltransferase) Activator DS-8190a Prevents the Progression of Plaque Accumulation in Atherosclerosis Models.
    Sasaki M; Delawary M; Sakurai H; Kobayashi H; Nakao N; Tsuru H; Fukushima Y; Honzumi S; Moriyama S; Wada N; Kaneko T; Yamada K; Terasaka N; Kubota K
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):360-376. PubMed ID: 33086872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
    O K; Hill JS; Pritchard PH
    Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles.
    Manthei KA; Patra D; Wilson CJ; Fawaz MV; Piersimoni L; Shenkar JC; Yuan W; Andrews PC; Engen JR; Schwendeman A; Ohi MD; Tesmer JJG
    Commun Biol; 2020 Jan; 3(1):28. PubMed ID: 31942029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I.
    Manthei KA; Ahn J; Glukhova A; Yuan W; Larkin C; Manett TD; Chang L; Shayman JA; Axley MJ; Schwendeman A; Tesmer JJG
    J Biol Chem; 2017 Dec; 292(49):20313-20327. PubMed ID: 29030428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Naturally Occurring Lecithin:Cholesterol Acyltransferase Mutants by a Novel Activator Compound.
    Pavanello C; Ossoli A; Turri M; Strazzella A; Simonelli S; Laurenzi T; Kono K; Yamada K; Kiyosawa N; Eberini I; Calabresi L
    J Pharmacol Exp Ther; 2020 Dec; 375(3):463-468. PubMed ID: 32980814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Insights into the Activation of Lecithin-Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids.
    Giorgi L; Niemelä A; Kumpula EP; Natri O; Parkkila P; Huiskonen JT; Koivuniemi A
    Mol Pharm; 2022 Nov; 19(11):4135-4148. PubMed ID: 36111986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural differences between wild-type and fish eye disease mutant of lecithin:cholesterol acyltransferase.
    Reshetnyak Y; Tchedre KT; Nair MP; Pritchard PH; Lacko AG
    J Biomol Struct Dyn; 2006 Aug; 24(1):75-82. PubMed ID: 16780378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial lecithin:cholesterol acyltransferase deficiency: First-in-human treatment with enzyme replacement.
    Shamburek RD; Bakker-Arkema R; Auerbach BJ; Krause BR; Homan R; Amar MJ; Freeman LA; Remaley AT
    J Clin Lipidol; 2016; 10(2):356-67. PubMed ID: 27055967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase.
    Holleboom AG; Kuivenhoven JA; van Olden CC; Peter J; Schimmel AW; Levels JH; Valentijn RM; Vos P; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Hollak CE
    Atherosclerosis; 2011 May; 216(1):161-5. PubMed ID: 21315357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency.
    Yang XP; Inazu A; Honjo A; Koizumi I; Kajinami K; Koizumi J; Marcovina SM; Albers JJ; Mabuchi H
    J Lipid Res; 1997 Mar; 38(3):585-91. PubMed ID: 9101439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
    Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
    J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase.
    Glukhova A; Hinkovska-Galcheva V; Kelly R; Abe A; Shayman JA; Tesmer JJ
    Nat Commun; 2015 Mar; 6():6250. PubMed ID: 25727495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BacMam production of active recombinant lecithin-cholesterol acyltransferase: Expression, purification and characterization.
    Romanow WG; Piper DE; Fordstrom P; Thibault S; Zhou M; Walker NP
    Protein Expr Purif; 2016 Sep; 125():1-6. PubMed ID: 26363122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LCAT- targeted therapies: Progress, failures and future.
    Yang K; Wang J; Xiang H; Ding P; Wu T; Ji G
    Biomed Pharmacother; 2022 Mar; 147():112677. PubMed ID: 35121343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Tolerability of ACP-501, a Recombinant Human Lecithin:Cholesterol Acyltransferase, in a Phase 1 Single-Dose Escalation Study.
    Shamburek RD; Bakker-Arkema R; Shamburek AM; Freeman LA; Amar MJ; Auerbach B; Krause BR; Homan R; Adelman SJ; Collins HL; Sampson M; Wolska A; Remaley AT
    Circ Res; 2016 Jan; 118(1):73-82. PubMed ID: 26628614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.